Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(18%)
Results Posted
25%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
2
18%
Ph not_applicable
3
27%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (40.0%)
N/A3 (60.0%)

Trials by Status

terminated19%
not_yet_recruiting19%
unknown327%
completed436%
recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11